Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RBT-3 in Healthy Volunteers and Chronic Kidney Disease Stage 3/4
NCT04072432Phase 1Completed
- Sponsor
- Renibus Therapeutics
- Start
- Oct 2018
- Primary completion
- Mar 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of iron sucrose in chronic kidney disease (CKD), sponsored by Renibus Therapeutics. Started Oct 2018; status: completed.
02
Drugs
iron sucrose
03
Conditions
chronic kidney disease (CKD)
Beyond the preview
Go deeper on NCT04072432.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04072432.